Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Share price - Overview

Stock Report

Agios Pharmaceuticals Inc AGIO

Last Price
$90.01

Day Change
-0.39|-0.43%

As of 16/07/2018
16:09:42 EDT | USD
Minimum 15 Minutes Delay.

Last Close90.40
Day Range88.12 - 91.30
Mkt Cap5.19Bil
52-Wk Range51.62 - 99.82
Yield %-
ISINUS00847X1046
Volume235,745
P/E-13.20
P/S108.70
P/CF-14.49

Share Price

Financials
201520162017
More ...
Income Statement
Revenue59.1269.8943.01
Operating Income-118.70-200.99-320.79
Net Income-117.73-198.47-314.67
Basic EPS-3.15-5.07-6.75
Avg. Diluted Shares Outstanding373947
Balance Sheet
Current Assets337.33559.89445.26
Non Current Assets82.7459.20169.14
Total Assets420.07619.09614.40
Current Liabilities52.8988.4394.94
Total Liabilities---
Total Equity345.12358.59375.50
Cash Flow
Operating Cash Flow-76.9538.56-285.23
Capital Expenditure-20.16-9.92-4.63
Free Cash Flow-97.1128.65-289.86

In millions, except "Basic EPS". Currency is USD.

Company Profile

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

382
Key Stats
More ...
Price/Earning TTM-13.26
Price/Book6.02
Price/Sales TTM109.40
Rev Growth (3 year avg)-13.02
EPS Growth (3 year avg)-
Operating Margin % TTM-745.84
Net Margin % TTM-731.60
ROE TTM-85.73
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.